Grants & Projects per year
-
BHV2000-301: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Participants with Spinal Muscular Atrophy with Open-Label Extension (RESILIENT)
Treidler, S. (PI), Dawson, D. M. (CoPI) & Morelli, P. (CoPI)
Biohaven Pharmaceuticals Holding Company Ltd.
01/31/23 → 12/8/26
Project: Research
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
Treidler, S. (PI), Dawson, D. M. (CoPI) & Morelli, P. (CoPI)
06/6/23 → 02/28/26
Project: Research